Sadra Medical Closes $19M To Fund Development
Tuesday, October 24, 2006 9:00:00 AM PDT | VentureDeal Staff
CAMPBELL, CA --
Sadra Medical closed its Series B round and garnered $19 million more to continue development of aortic valve disease treatments.
Participating investors included Oakwood Medical Investors, Boston Scientific as well as Series A investors Pequot Ventures, Onset Ventures and SV Life Sciences Advisors.
The company is developing a percutaneous aortic valve replacement solution they call the "Sadra Lotus Valve."
Sadra Medical was founded in 2003 and previously received Series A funding of $9 million.
Email Page | Print Page